| Bisher Abdullah, MD | |
|
1004 E Main Ste D, Puyallup, WA 98372-3199 | |
| (253) 268-0720 | |
| (253) 466-7072 |
| Full Name | Bisher Abdullah |
|---|---|
| Gender | Male |
| Speciality | Undefined Physician Type (specify) |
| Experience | 35 Years |
| Location | 1004 E Main Ste D, Puyallup, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235161712 | NPI | - | NPPES |
| 2080P0206X | Other | WA | TAXONOMY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summit Pacific Medical Center-swing Bed Unit | Elma, WA | Hospital |
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Entity Name | Grays Harbor County Public Hospital District No 1 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740211028 PECOS PAC ID: 9032017256 Enrollment ID: O20031226000146 |
News Archive
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
Atopic dermatitis (AD), a chronic inflammatory skin condition and the most common form of eczema, is estimated to afflict as much as 10 percent of the U.S. population, and is much more common now than it was 50 years ago. Veterinary clinical estimates also show that approximately 10 percent of dogs have atopic dermatitis.
Researchers with the National Human Genome Research Institute, part of the National Institutes of Health, and their collaborators, have successfully used facial recognition software to diagnose a rare, genetic disease in Africans, Asians and Latin Americans.
Nevada Attorney General Brian Sandoval has announced that the percentage of stores that sold cigarettes and other tobacco products to minors has dropped to 8.2% in July.
› Verified 7 days ago
| Entity Name | Center For Minimally Invasive Surgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699950253 PECOS PAC ID: 1658344817 Enrollment ID: O20040816001147 |
News Archive
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
Atopic dermatitis (AD), a chronic inflammatory skin condition and the most common form of eczema, is estimated to afflict as much as 10 percent of the U.S. population, and is much more common now than it was 50 years ago. Veterinary clinical estimates also show that approximately 10 percent of dogs have atopic dermatitis.
Researchers with the National Human Genome Research Institute, part of the National Institutes of Health, and their collaborators, have successfully used facial recognition software to diagnose a rare, genetic disease in Africans, Asians and Latin Americans.
Nevada Attorney General Brian Sandoval has announced that the percentage of stores that sold cigarettes and other tobacco products to minors has dropped to 8.2% in July.
› Verified 7 days ago
| Entity Name | Prime Health Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710306436 PECOS PAC ID: 4981823051 Enrollment ID: O20140923000675 |
News Archive
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
Atopic dermatitis (AD), a chronic inflammatory skin condition and the most common form of eczema, is estimated to afflict as much as 10 percent of the U.S. population, and is much more common now than it was 50 years ago. Veterinary clinical estimates also show that approximately 10 percent of dogs have atopic dermatitis.
Researchers with the National Human Genome Research Institute, part of the National Institutes of Health, and their collaborators, have successfully used facial recognition software to diagnose a rare, genetic disease in Africans, Asians and Latin Americans.
Nevada Attorney General Brian Sandoval has announced that the percentage of stores that sold cigarettes and other tobacco products to minors has dropped to 8.2% in July.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bisher Abdullah, MD 1004 E Main Ste D, Puyallup, WA 98372-3199 Ph: (253) 740-0977 | Bisher Abdullah, MD 1004 E Main Ste D, Puyallup, WA 98372-3199 Ph: (253) 268-0720 |
News Archive
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
Atopic dermatitis (AD), a chronic inflammatory skin condition and the most common form of eczema, is estimated to afflict as much as 10 percent of the U.S. population, and is much more common now than it was 50 years ago. Veterinary clinical estimates also show that approximately 10 percent of dogs have atopic dermatitis.
Researchers with the National Human Genome Research Institute, part of the National Institutes of Health, and their collaborators, have successfully used facial recognition software to diagnose a rare, genetic disease in Africans, Asians and Latin Americans.
Nevada Attorney General Brian Sandoval has announced that the percentage of stores that sold cigarettes and other tobacco products to minors has dropped to 8.2% in July.
› Verified 7 days ago
Mr. Michael Lane Pearson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 12904 94th Ave East, Puyallup, WA 98373 Phone: 253-841-3999 Fax: 253-841-7311 | |
Angela A Viniarski, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1706 Meridian S, Suite 120, Puyallup, WA 98371 Phone: 253-848-8797 Fax: 253-446-3239 | |
Andrew T Sledd, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1007 39th Ave Se, Puyallup, WA 98374 Phone: 253-435-3100 Fax: 253-435-3298 | |
Dr. Victoria Devere, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1700 5th St Se, Puyallup, WA 98372 Phone: 253-848-8797 | |
Roselynn Wee Sim Cuenca, M.D., M.P.H. Pediatrics Medicare: Medicare Enrolled Practice Location: 1910 Meridian St S, Ste A, Puyallup, WA 98371 Phone: 253-848-2303 | |
Edward J Husarik, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1706 Meridian S, Suite 120, Puyallup, WA 98371 Phone: 253-848-8797 Fax: 253-446-3239 | |
Taylor Ryan Mclain, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11102 Sunrise Blvd E Ste 103, Puyallup, WA 98374 Phone: 253-848-8797 |